BU-NOT-SET

CONTACT US
Product Quality in the Advanced Therapies Manufacturing
  • Biologics
men in lab
White paper
Navigating ATMP fill and finish complexities
  • Biologics
lab
Insight
The power of analytics and AI in the era of continuous RNA manufacturing
  • Biologics
people in a lab
Insight
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
  • Biologics
person in lab
Insight
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
  • Biologics
mRNA
Insight
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
  • Biologics
vaccine in bottles
Insight
Choosing the optimal container format for sterile drug products
  • Drug product
  • Manufacturing
Containers for sterile drug products
Insight
FDA inspection success at Recipharm’s site in Bengaluru, India
  • Manufacturing
Two people looking at a printed document
Insight
Lyophilisation Services
  • Drug product
  • Manufacturing
bottles
Fact sheet
Insight
  • Manufacturing
Serialisation | the past, the present and the future
Insight
  • Industry trends
Mergers and acquisitions | meeting customer demand
Insight
  • Manufacturing
DSCSA deadline | our views
Insight
  • Manufacturing
Serialisation: an investment not an expense
Insight
  • Drug product
Solving the solubility setback
Insight
  • Industry trends
Pharmaceutical mega-trends: the rise of consolidation
Insight
  • Manufacturing
What the new Drug Supply Chain Security Act (DSCSA) deadline means for the industry
Insight
  • Drug substance
Automating excipient selection using high-throughput screening
Insight
  • Manufacturing
Serialisation: is the industry ready?